» Authors » Shohei Morikawa

Shohei Morikawa

Explore the profile of Shohei Morikawa including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 33
Citations 148
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Murakami T, Okamoto F, Sugiura Y, Izumi I, Iioka A, Morikawa S, et al.
Ophthalmologica . 2024 Feb; 247(2):107-117. PMID: 38408439
Introduction: We compared postoperative metamorphopsia and optical coherence tomography (OCT) findings between eyes that underwent internal limiting membrane (ILM) peeling and the inverted flap (IF) technique for macular hole (MH)....
2.
Morikawa S, Okamoto F, Murakami T, Sugiura Y, Oshika T
PLoS One . 2024 Feb; 19(2):e0297134. PMID: 38335184
Purpose: To compare stereopsis and foveal microstructure after internal limiting membrane peeling and inverted internal limiting membrane flap technique in patients with macular hole. Design: Retrospective observational study. Methods: Sixty-six...
3.
Okamoto F, Murakami T, Morikawa S, Sugiura Y, Hiraoka T, Oshika T
J Clin Med . 2023 Feb; 12(4). PMID: 36836062
Even after successful surgery, the stereopsis of retinal detachment (RD) patients is inferior to that of normal subjects. However, it is unclear which visual dysfunction in the affected eye is...
4.
Yoshimura A, Ishikawa H, Uchida K, Takesue Y, Mori J, Kinoshita T, et al.
Ocul Immunol Inflamm . 2023 Jan; 32(7):1133-1141. PMID: 36701518
Purpose: We investigated potential risk factors for visual prognosis in Japanese patients with exogenous endophthalmitis. Methods: In this retrospective observational multicenter cohort study, risk factors for legal blindness at 12 ...
5.
Okamoto F, Murakami T, Sugiura Y, Morikawa S, Hiraoka T, Oshika T
Jpn J Ophthalmol . 2022 Oct; 67(1):59-65. PMID: 36301446
Purpose: To evaluate the vision-related quality of life (VR-QOL) before and after intravitreal ranibizumab injections (IVR) for central retinal vein occlusion (CRVO) and to investigate subscale items of VR-QOL in...
6.
Murakami T, Okamoto F, Sugiura Y, Morikawa S, Okamoto Y, Hiraoka T, et al.
Sci Rep . 2022 Oct; 12(1):17356. PMID: 36253499
The aim of the present study was to investigate changes in metamorphopsia in patients with diabetic macular edema (DME) following intravitreal aflibercept injection (IVA) with the treat and extend (TAE)...
7.
Sugisawa T, Ishikawa H, Uchida K, Takesue Y, Mori J, Kinoshita T, et al.
Ocul Immunol Inflamm . 2022 Aug; 31(7):1505-1512. PMID: 36007241
Purpose: We investigated potential predictive factors for visual prognosis in Japanese patients with endogenous endophthalmitis. Design: Retrospective observational multicenter cohort study. Methods: We examined the characteristics of 77 Japanese patients...
8.
Morikawa S, Okamoto F, Murakami T, Sugiura Y, Hiraoka T, Okamoto Y, et al.
Sci Rep . 2022 Aug; 12(1):13428. PMID: 35927561
To evaluate the vision-related quality of life (VR-QOL) treated by intravitreal ranibizumab (IVR) in patients with branch retinal vein occlusion (BRVO) and to assess subscale items of the VR-QOL. This...
9.
Murakami T, Okamoto F, Sugiura Y, Morikawa S, Okamoto Y, Hiraoka T, et al.
J Clin Med . 2022 Jul; 11(14). PMID: 35887902
Visual functions that affect vision-related quality of life (VR-QoL) before and after intravitreal injection of ranibizumab in patients with cystoid macular edema secondary to central retinal vein occlusion (CRVO-CME) are...
10.
Hoshi S, Tasaki K, Maruo K, Ueno Y, Mori H, Morikawa S, et al.
J Clin Med . 2022 Apr; 11(8). PMID: 35456168
Recently, a minimally invasive treatment for lacrimal passage diseases was developed using dacryoendoscopy. Good visibility of the lacrimal passage is important for examination and treatment. This study aimed to investigate...